Fig. 2
It illustrates the association of each miRNA with (A) liraglutide, (B) semaglutide, and (C) exenatide for controlling cardiovascular diseases, hyperglycemia, and obesity in individuals with T2DM
Fig. 2 | Diabetology & Metabolic Syndrome